Presentations
Repairing the defective skin barrier in atopic dermatitis
Presented by Michael J. Cork & Simon G. Danby at the World Congress of Dermatology, Singapore, July 2023
Dupilumab Treatment Normalises Skin Barrier Function in Children Aged 6 to 11 Years With Moderate-to-Severe Atopic Dermatitis
Presented by Simon G. Danby at the EAACI meeting, Hamburg, June 2023
Skin Testing to determine Atopic dermatitis Risk: an observational birth cohort study
Presented by John Chittock, Linda Kay, Kirsty Brown, Alison Cooke, Tina Lavender, Simon G. Danby & Michael J. Cork at ISAD meeting, Montreal, October 2022
Novel non-invasive skin biomarkers discriminate topical anti-inflammatory treatments based on their potential for local adverse effects
Presented by Simon G. Danby, Stephen Matcher, Robert Byers, Rosie Taylor, Sura Sahib, Paul Andrew, Kirsty Brown, Linda Kay, Carl Wright, Abi Pinnock, John Chittock, Amy Cha, Roni Adiri, Chuanbo Zang, John Werth & Michael J. Cork at EADV meeting, Milan, September 2022
The anti-viral effects of different hand washing practices and the implications for occupational hand dermatoses
Presented by Natalie Winder, Michael Cork, Simon Danby & Munitta Muthana at EADV meeting, Milan, September 2022
CeraVe Hub Presentation
Late Breaker
What is the role of moisturisers in the development and prevention of allergy?
Presented by Dr Oludolapo Sherifat Katibi at DRIP meeting, Sheffield, April 2021
Skin Pathology assessment with Optical Technologies
Presented by Robert Byers at DRIP meeting, Sheffield, February 2021
Characterising Skin Barrier Defects Using ATR-FTIR
Presented by Samuel Williams at DRIP meeting, Sheffield, January 2021
L’Oréal is the world’s largest personal care company. The Active Cosmetics Division of L’Oréal, comprising the Vichy, La Roche-Posay, SkinCeuticals, Roger & Gallet, CeraVe and Sanoflore brands, is a world leader in dermocosmetics.
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. The Spectroscopy Division of Agilent has developed handheld spectroscopy instrumentation which is gaining rapid acceptance in a wide variety of application areas, most recently including skin analysis.
The aim of this project is to develop novel dermocosmetic applications for FTIR spectroscopy using the Agilent 4300 spectrometer. We have already shown that FTIR can be used in vivo to quantify the skin barrier defect in patients with eczema, and that this measurement could potentially help direct preventative therapies towards those most at risk.
Working in partnership with L’Oréal and Agilent the student will undertake a program of research, involving in vivo human skin testing, to develop new analytical methods to quantify skin properties that will help support future product development and testing.
Treating atopic dermatitis, ICD and ACD in the context of SARS-Cov-2 infection
Presented by Michael J. Cork at the 29th EADV Virtual Congress 2020
Novel systemic treatments in paediatrics and placebo responses in systemic trials
Presented by Michael J. Cork at the 29th EADV Virtual Congress 2020
Restoring Skin Barrier Function: Why Formulation Matters
With the implications of hand-washing protocol during the COVID-19 pandemic, proper skin-barrier restoration is essential, especially for people with dry, eczema-prone skin.
Tune in as Professor Michael J. Cork BSC MB PhD FRCP and Professor Simon G. Danby discuss the skin-barrier restoring effect of a cream containing ceramides in a multi-vesicular emulsion for people with eczema-prone skin, as well as other skin conditions that require skin-barrier restoration.
Hosted by JDD
Sponsored by CeraVe
Presented on July 23, 2020
